Telemedicine for patients with rheumatic diseases: systematic review and proposal for research agenda
Objective To systematically review the scientific literature regarding tele-rheumatology and
draw conclusions about feasibility, effectiveness, and patient satisfaction. Methods PubMed …
draw conclusions about feasibility, effectiveness, and patient satisfaction. Methods PubMed …
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid …
…, O Berardicurti, F Carubbi, A Cauli… - Autoimmunity …, 2017 - Elsevier
Autoimmune diseases are a complex set of diseases characterized by immune system
activation and, although many progresses have been done in the last 15 years, several …
activation and, although many progresses have been done in the last 15 years, several …
Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis
…, WH Boehncke, W Campbell, A Cauli… - Arthritis & …, 2016 - Wiley Online Library
Objective To update the 2009 Group for Research and Assessment of Psoriasis and
Psoriatic Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations …
Psoriatic Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations …
The interplay between the geographic distribution of HLA-B27 alleles and their role in infectious and autoimmune diseases: a unifying hypothesis
A Mathieu, F Paladini, A Vacca, A Cauli, MT Fiorillo… - Autoimmunity …, 2009 - Elsevier
Due to its strong association with Ankylosing Spondylitis and the other
Spondyloarthropathies, the HLA-B27 family of alleles and, in particular, the ancestral HLA …
Spondyloarthropathies, the HLA-B27 family of alleles and, in particular, the ancestral HLA …
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide
…, D Abramovicz, D Blockmans, A Cauli… - Annals of the …, 2010 - ard.bmj.com
Objective: To update the follow-up of the Euro-Lupus Nephritis Trial (ELNT), a randomised
prospective trial comparing low-dose (LD) and high-dose (HD) intravenous (IV) …
prospective trial comparing low-dose (LD) and high-dose (HD) intravenous (IV) …
Consensus on a core set of domains for psoriatic arthritis.
A psoriatic arthritis (PsA) module was convened at OMERACT 8 in order to achieve
consensus on the core domains that should be included in randomized controlled trials and …
consensus on the core domains that should be included in randomized controlled trials and …
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)
…, VF Azevedo, AB Ostos, S Carneiro, A Cauli… - Annals of the …, 2013 - ard.bmj.com
Objective To develop new composite disease activity indices for psoriatic arthritis (PsA).
Methods Data from routine clinic visits at multiple centres were collected in a systematic …
Methods Data from routine clinic visits at multiple centres were collected in a systematic …
[HTML][HTML] Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven …
…, S Kelly, PP Sainaghi, N Gendi, B Dasgupta, A Cauli… - The Lancet, 2021 - thelancet.com
Background Although targeted biological treatments have transformed the outlook for
patients with rheumatoid arthritis, 40% of patients show poor clinical response, which is …
patients with rheumatoid arthritis, 40% of patients show poor clinical response, which is …
[PDF][PDF] Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes
…, R Landewé, A van der Helm-van Mil, A Cauli… - Cell reports, 2019 - cell.com
There is a current imperative to unravel the hierarchy of molecular pathways that drive the
transition of early to established disease in rheumatoid arthritis (RA). Herein, we report a …
transition of early to established disease in rheumatoid arthritis (RA). Herein, we report a …
Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients
…, A van der Helm-van Mil, A Cauli… - Annals of the …, 2019 - ard.bmj.com
Objectives To unravel the hierarchy of cellular/molecular pathways in the disease tissue of
early, treatment-naïve rheumatoid arthritis (RA) patients and determine their relationship …
early, treatment-naïve rheumatoid arthritis (RA) patients and determine their relationship …